The Prognostication of Surgically Resected Head and Neck Squamous Cell Carcinoma Using Pre‐Therapy Neutrophil and Lymphocyte Counts
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | Pranit R. Sunkara, Emily Chow, Jacob Waitzman, Ammar Sukari, John D. Cramer |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2024
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Prediction and Prognostication of Peripheral Blood Biomarkers in Head and Neck Cutaneous Squamous Cell Carcinoma
di: Mikayla G. Hubbard, et al.
Pubblicazione: (2026)
di: Mikayla G. Hubbard, et al.
Pubblicazione: (2026)
Risk Factors for Progressive Disease After Immune Checkpoint Inhibitor Therapy in Head and Neck Squamous Cell Carcinoma
di: Seo Yoon Jang, et al.
Pubblicazione: (2025)
di: Seo Yoon Jang, et al.
Pubblicazione: (2025)
Association of Socioeconomic Factors and Immunotherapy in Cutaneous Squamous Cell Carcinoma of the Head and Neck
di: Christie Hung, et al.
Pubblicazione: (2026)
di: Christie Hung, et al.
Pubblicazione: (2026)
Aggressive Head and Neck Squamous Cell Carcinoma in the Setting of GATA2 Deficiency
di: Brejjette Aljabi, et al.
Pubblicazione: (2025)
di: Brejjette Aljabi, et al.
Pubblicazione: (2025)
Examining the Interaction Between Sex and Race in Outcomes of Head and Neck Squamous Cell Carcinoma
di: Geena Jung, et al.
Pubblicazione: (2025)
di: Geena Jung, et al.
Pubblicazione: (2025)
First‐Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective, Multicenter, Real‐World Study
di: Alizée Simon, et al.
Pubblicazione: (2025)
di: Alizée Simon, et al.
Pubblicazione: (2025)
Impact of Extranodal Extension in Patients With Regional Metastases of Head and Neck Cutaneous Squamous Cell Carcinoma
di: Rachel Braude, et al.
Pubblicazione: (2026)
di: Rachel Braude, et al.
Pubblicazione: (2026)
Aberrant Splicing Burden Predicts Immune Infiltration and Prognosis in Head and Neck Squamous Cell Carcinomas
di: Sandhya Kalavacherla, et al.
Pubblicazione: (2025)
di: Sandhya Kalavacherla, et al.
Pubblicazione: (2025)
Postoperative Adjuvant Therapy in Resectable Advanced Oral Squamous Cell Carcinoma With Intermediate Risk Factors
di: Koichi Koizumi, et al.
Pubblicazione: (2025)
di: Koichi Koizumi, et al.
Pubblicazione: (2025)
Detection of Circulating Cancer‐Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma and Their Impact on Circulating Tumor Cells
di: Kazuaki Chikamatsu, et al.
Pubblicazione: (2025)
di: Kazuaki Chikamatsu, et al.
Pubblicazione: (2025)
Impact of Prior Neck Treatment Status on Salvage Treatment Outcomes in Isolated Regional Recurrence of Head and Neck Squamous Cell Carcinoma
di: Younghac Kim, et al.
Pubblicazione: (2025)
di: Younghac Kim, et al.
Pubblicazione: (2025)
Cigarette Smoke Exposure Attenuates T2R ‐Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma
di: Kyle Polen, et al.
Pubblicazione: (2026)
di: Kyle Polen, et al.
Pubblicazione: (2026)
The Role of Multicancer Early Detection Tests in Head and Neck Squamous Cell Carcinoma: A Case Series
di: Abhinav Talwar, et al.
Pubblicazione: (2026)
di: Abhinav Talwar, et al.
Pubblicazione: (2026)
Examining the Impact of Race and Sex on the Incidence of Positive Surgical Margins in Oral Cavity Squamous Cell Carcinoma
di: Jacob S. Brady, et al.
Pubblicazione: (2025)
di: Jacob S. Brady, et al.
Pubblicazione: (2025)
Efficacy and Failure Patterns Following Target Volume and Dose Reduction After Neoadjuvant Therapy in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
di: Xiong Zhou, et al.
Pubblicazione: (2024)
di: Xiong Zhou, et al.
Pubblicazione: (2024)
Surgical Approaches to Pre‐Auricular Cutaneous Squamous Cell Carcinomas Extending to the Temporal Bone
di: Michael Schachtel, et al.
Pubblicazione: (2025)
di: Michael Schachtel, et al.
Pubblicazione: (2025)
Evaluation of a Novel Prognostic System for Surgically Resected Oral Cavity Carcinoma
di: Alisa Rybkin, et al.
Pubblicazione: (2025)
di: Alisa Rybkin, et al.
Pubblicazione: (2025)
Hypoxia and Oxidation Pathway Crosstalk in Head and Neck Squamous Cell Carcinoma
di: Abdullah A. Adil, et al.
Pubblicazione: (2026)
di: Abdullah A. Adil, et al.
Pubblicazione: (2026)
Recurrence Patterns of Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
di: Nikhil Bellamkonda, et al.
Pubblicazione: (2024)
di: Nikhil Bellamkonda, et al.
Pubblicazione: (2024)
Efficacy of Multimodal Work‐Up of Head and Neck Squamous Cell Carcinoma Lymph Node Metastasis of Unknown Primary
di: Robin W. Jansen, et al.
Pubblicazione: (2025)
di: Robin W. Jansen, et al.
Pubblicazione: (2025)
Survival Impact of Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A National Cancer Database Analysis
di: Rohan Vuppala, et al.
Pubblicazione: (2025)
di: Rohan Vuppala, et al.
Pubblicazione: (2025)
Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
di: Aarti Bhatia, et al.
Pubblicazione: (2025)
di: Aarti Bhatia, et al.
Pubblicazione: (2025)
Association of Absolute Neutrophil Count With Outcomes in Patients With Head and Neck Cancer Receiving Definitive Chemoradiation
di: Jasmin Gill, et al.
Pubblicazione: (2026)
di: Jasmin Gill, et al.
Pubblicazione: (2026)
Early and Long‐Term Thyroid Dysfunction in Patients With Head and Neck Squamous Cell Carcinoma After External Radiotherapy: Clinicopathological Risk Factors
di: Adriana Russo Fiore, et al.
Pubblicazione: (2025)
di: Adriana Russo Fiore, et al.
Pubblicazione: (2025)
Pretreatment Neutrophil‐to‐Lymphocyte Ratio ( NLR ) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study
di: Raisa Chowdhury, et al.
Pubblicazione: (2025)
di: Raisa Chowdhury, et al.
Pubblicazione: (2025)
Impact of Extranodal Extension in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Systematic Review and Meta‐Analysis
di: Andrea Costantino, et al.
Pubblicazione: (2025)
di: Andrea Costantino, et al.
Pubblicazione: (2025)
Altered Bacteria Abundance Is Associated With Outcomes in Head and Neck Squamous Cell Carcinoma
di: Delaney H. Sheehan, et al.
Pubblicazione: (2025)
di: Delaney H. Sheehan, et al.
Pubblicazione: (2025)
The Burden of Recurrent Head and Neck Squamous Cell Carcinoma Across the United Kingdom: Results From a National Snapshot Study
di: Andrew Williamson, et al.
Pubblicazione: (2024)
di: Andrew Williamson, et al.
Pubblicazione: (2024)
Prognosis After Discontinued Treatment due to Immune‐Related Adverse Events in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
di: Hiromasa Ishihara, et al.
Pubblicazione: (2025)
di: Hiromasa Ishihara, et al.
Pubblicazione: (2025)
Exploratory Biomarker Analysis of Abemaciclib in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma With Dysregulated CDK4 /6 Pathway
di: Joo‐Hwan Park, et al.
Pubblicazione: (2026)
di: Joo‐Hwan Park, et al.
Pubblicazione: (2026)
Safety and Efficacy of Intra‐Arterial Chemotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma
di: Chao Yang, et al.
Pubblicazione: (2025)
di: Chao Yang, et al.
Pubblicazione: (2025)
Surgical Versus Non‐Surgical Treatment of Advanced Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis
di: Megan K. Scharner, et al.
Pubblicazione: (2025)
di: Megan K. Scharner, et al.
Pubblicazione: (2025)
Variations in Treatment Prescription and Survival Outcomes Between Older and Younger Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Radiotherapy
di: Farhannah Aly, et al.
Pubblicazione: (2026)
di: Farhannah Aly, et al.
Pubblicazione: (2026)
Oncological Outcomes of Salvage Oropharyngectomy in Irradiated Neck for Recurrent or Metachronous Squamous Cell Carcinoma
di: Jade Saykaly, et al.
Pubblicazione: (2026)
di: Jade Saykaly, et al.
Pubblicazione: (2026)
Bilateral Neck Dissection in cN0 Supraglottic Squamous Cell Carcinoma: Essential or Not?
di: Jiamei Wen, et al.
Pubblicazione: (2025)
di: Jiamei Wen, et al.
Pubblicazione: (2025)
A Comprehensive Immune Checkpoint Phenotype Predicts Response and Survival to PD ‐1 Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
di: Mathias Fiedler, et al.
Pubblicazione: (2026)
di: Mathias Fiedler, et al.
Pubblicazione: (2026)
Alternative MYB Promoter Activity Is a Potential Prognostic Biomarker in Head and Neck Adenoid Cystic Carcinoma
di: Fredrik Jäwert, et al.
Pubblicazione: (2025)
di: Fredrik Jäwert, et al.
Pubblicazione: (2025)
The Prognostic Implications of Neutrophil‐to‐Lymphocyte Ratio in Olfactory Neuroblastoma
di: Joseph Mocharnuk, et al.
Pubblicazione: (2024)
di: Joseph Mocharnuk, et al.
Pubblicazione: (2024)
Evaluating Depth of Invasion as a Continuous Prognostic Factor in Oral Squamous Cell Carcinoma
di: Nofar Edri, et al.
Pubblicazione: (2024)
di: Nofar Edri, et al.
Pubblicazione: (2024)
Persistent Opioid Use Following Resection of Oral Cavity Squamous Cell Carcinoma: Incidence and Risk Factors
di: Cameron C. Lee, et al.
Pubblicazione: (2025)
di: Cameron C. Lee, et al.
Pubblicazione: (2025)
Documenti analoghi
-
Prediction and Prognostication of Peripheral Blood Biomarkers in Head and Neck Cutaneous Squamous Cell Carcinoma
di: Mikayla G. Hubbard, et al.
Pubblicazione: (2026) -
Risk Factors for Progressive Disease After Immune Checkpoint Inhibitor Therapy in Head and Neck Squamous Cell Carcinoma
di: Seo Yoon Jang, et al.
Pubblicazione: (2025) -
Association of Socioeconomic Factors and Immunotherapy in Cutaneous Squamous Cell Carcinoma of the Head and Neck
di: Christie Hung, et al.
Pubblicazione: (2026) -
Aggressive Head and Neck Squamous Cell Carcinoma in the Setting of GATA2 Deficiency
di: Brejjette Aljabi, et al.
Pubblicazione: (2025) -
Examining the Interaction Between Sex and Race in Outcomes of Head and Neck Squamous Cell Carcinoma
di: Geena Jung, et al.
Pubblicazione: (2025)